| Zarzio 30 MU (60 MU/ml) Solution for injection or EU/1/08/495/1-4,9-12 |
Ep2006 (recombinant human granulocyte-colony stimulating factor) |
Sandoz GmbH |
— |
| Zarzio 48 MU (96 MU/ml) Solution for injection or EU/1/08/495/5-8,13-16 |
Ep2006 (recombinant human granulocyte-colony stimulating factor) |
Sandoz GmbH |
— |
| Zavesca 100 mg capsules EU/1/02/238/001 |
Miglustat |
Janssen-Cilag International NV |
— |
| Zavicefta 2 g/0.5 g powder for concentrate for solution for infusion EU/1/16/1109/001 |
Avibactam sodium, Ceftazidime pentahydrate |
Pfizer Ireland Pharmaceuticals |
— |
| Zebinix 200 mg Tablet EU/1/09/514/021-023 |
Eslicarbazepine acetate |
BIAL-Portela & Ca, S.A. |
— |
| Zebinix 400 mg Tablet EU/1/09/514/1-6 |
Eslicarbazepine acetate |
BIAL-Portela & Ca, S.A. |
— |
| Zebinix 50 mg/ml Oral suspension EU/1/09/514/024 |
Eslicarbazepine acetate |
BIAL-Portela & Ca, S.A. |
— |
| Zebinix 600 mg Tablet EU/1/09/514/7-11 |
Eslicarbazepine acetate |
BIAL-Portela & Ca, S.A. |
— |
| Zebinix 800 mg Tablet EU/1/09/514/12-20 |
Eslicarbazepine acetate |
BIAL-Portela & Ca, S.A. |
— |
| Zeffix 100 mg Film-coated tablet EU/1/99/114/001 |
Lamivudine |
GlaxoSmithKline Trading Services Limited |
— |
| Zeffix 100 mg Film-coated tablet EU/1/99/114/002 |
Lamivudine |
GlaxoSmithKline Trading Services Limited |
— |
| Zeffix 5 mg/ml Oral solution EU/1/99/114/003 |
Lamivudine |
GlaxoSmithKline Trading Services Limited |
— |
| Zefylti 30 MU/0.5 mL solution for injection/infusion in pre-filled syringe EU/1/24/1899/001-004 |
Filgrastim |
Curateq Biologics s.r.o. |
— |
| Zefylti 48 MU/0.5 mL solution for injection/infusion in pre-filled syringe EU/1/24/1899/005-008 |
Filgrastim |
Curateq Biologics s.r.o. |
— |
| Zegalogue 0.6 mg solution for injection in pre-filled syringe EU/1/24/1829/001-004 |
Dasiglucagon hydrochloride |
Zealand Pharma A/S |
— |
| Zejula 100 mg Capsule, hard EU/1/17/1235/001-003 |
Niraparib tosylate monohydrate |
GlaxoSmithKline Trading Services Limited |
— |
| Zejula 100 mg Film-coated tablet EU/1/17/1235/004-005 |
Niraparid tosylate monohydrate |
GlaxoSmithKline Trading Services Limited |
— |
| Zelboraf 240 mg film-coated tablets EU/1/12/751/001 |
Vemurafenib |
Roche Registration GmbH |
— |
| Zemcelpro = 0.23×106 viable CD34+ cells/mL/= 0.53×106 viable CD3+ cells/mL dispersion for infusion EU/1/25/1960/001 |
Haematopoietic stem cells and blood progenitor umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate |
Cordex Biologics International Limited |
— |
| ZEPATIER 50 mg/100 mg film-coated tablets EU/1/16/1119/001 |
Grazoprevir, Elbasvir |
Merck Sharp & Dohme BV, |
— |
| Zeposia 0.23 mg hard capsules Zeposia 0.46 mg hard capsules EU/1/20/1442/001 |
OZANIMOD |
Bristol-Myers Squibb Pharma EEIG |
— |
| Zeposia 0.92 mg hard capsules EU/1/20/1442/002-003 |
OZANIMOD |
Bristol-Myers Squibb Pharma EEIG |
— |
| Zerbaxa 1 g/0.5 g powder for concentrate for solution for infusion EU/1/15/1032/001 |
Ceftolozane sulfate, Tazobactam sodium |
Merck Sharp & Dohme BV, |
— |
| Zercepac 150 mg Powder for concentrate for solution for infusion EU/1/20/1456/001 |
Trastuzumab |
Accord Healthcare S.L.U. |
— |
| Zercepac 420 mg powder for concentrate for solution for infusion EU/1/20/1456/003 |
Trastuzumab |
Accord Healthcare S.L.U. |
— |
| Zercepac 60 mg powder for concentrate for solution for infusion EU/1/20/1456/002 |
Trastuzumab |
Accord Healthcare S.L.U. |
— |
| Zerseos 0.5 mg/2.5 mg per 2.5 ml nebuliser solution PA1963/020/001 |
Ipratropium bromide monohydrate, Salbutamol |
Cipla Europe |
Not marketed |
| Zessly 100 mg powder for concentrate for solution for infusion EU/1/18/1280/001-005 |
Infliximab |
Sandoz GmbH |
— |
| Zevalin EU/1/03/264/001 |
Ibritumomabum tiuxetan |
Ceft Biopharma s.r.o |
— |
| Ziagen 20mg/mL Oral solution EU/1/99/112/002 |
Abacavir sulfate |
ViiV Healthcare BV |
— |
| Ziagen 300mg Film-coated table EU/1/99/112/001 |
Abacavir sulfate |
ViiV Healthcare BV |
— |
| Ziextenzo 6 mg solution for injection in pre-filled syringe EU/1/18/1327/001 |
Pegfilgrastim |
Sandoz GmbH |
— |
| Ziihera 300 mg powder for concentrate for solution for infusion EU/1/25/1931/001-002 |
Zanidatamab |
Jazz Pharmaceuticals Ireland Limited |
— |
| Zilbrysq 16.6 mg solution for injection in pre-filled syringe EU/1/23/1764/001-002 |
Zilucoplan |
UCB Pharma S.A. |
— |
| Zilbrysq 23 mg solution for injection in pre-filled syringe EU/1/23/1764/003-004 |
Zilucoplan |
UCB Pharma S.A. |
— |
| Zilbrysq 32.4 mg solution for injection in pre-filled syringe EU/1/23/1764/005-006 |
Zilucoplan |
UCB Pharma S.A. |
— |
| Zimbus Breezhaler 114 micrograms/46 micrograms/136 micrograms inhalation powder, hard capsules EU/1/20/1440/001-05 |
Indacaterol acetate, Glycopyrronium bromide, Mometasone furoate |
Novartis Europharm Limited |
— |
| Zinacef 1.5 g powder for solution for injection or infusion PA23311/002/003 |
Cefuroxime Sodium |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Zinacef 250 mg powder for solution for injection or infusion PA23311/002/001 |
Cefuroxime Sodium |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Zinacef 750 mg powder for solution for injection or infusion PA23311/002/002 |
Cefuroxime Sodium |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Zinforo 600 mg powder for concentrate for solution for infusion EU/1/12/785/001 |
Ceftaroline fosamil |
Pfizer Ireland Pharmaceuticals |
— |
| Zinnat 125 mg film-coated tablets PA23311/003/002 |
Cefuroxime |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Zinnat 125 mg/5 ml granules for oral suspension PA23311/003/005 |
Cefuroxime axetil |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Zinnat 250 mg film-coated tablets PA23311/003/003 |
Cefuroxime |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Zinnat 250mg/5ml granules for oral suspension PA23311/003/001 |
Cefuroxime axetil |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Zinnat 500 mg film-coated tablets PA23311/003/004 |
Cefuroxime |
Sandoz Pharmaceuticals d.d. |
Marketed |
| ZINPLAVA 25 mg/mL concentrate for solution for infusion EU/1/16/1156/001 |
Bezlotoxumab |
Merck Sharp & Dohme BV |
— |
| Zirabev 25 mg/ml concentrate for solution for infusion EU/1/18/1344/001-002 |
Bevacizumab |
Pfizer Europe MA EEIG |
— |
| Zirtek Plus Decongestant 5mg/120mg Prolonged Release Tablet PA0891/008/001 |
PSEUDOEPHEDRINE HYDROCHLORIDE, Cetirizine dihydrochloride |
UCB (Pharma) Ireland Limited, |
Marketed |
| Zitrease Allergy 10 mg Film-coated tablets PA1436/042/001 |
Cetirizine hydrochloride |
Bluefish Pharmaceuticals AB |
Not marketed |